Adagene Inc. (ADAG)

NASDAQ: ADAG · Real-Time Price · USD

1.960

-0.060 (-2.97%)

At close: Sep 26, 2025, 4:00 PM EDT

1.940

-0.020 (-1.02%)

After-hours: Sep 26, 2025, 7:29 PM EDT

Adagene Employees

Adagene had 138 employees as of December 31, 2024. The number of employees decreased by 36 or -20.69% compared to the previous year.

Employees

138

Change (1Y)

-36

Growth (1Y)

-20.69%

Revenue / Employee

$748

Profits / Employee

-$216,592

Market Cap

92.38M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	138	-36	-20.69%
Dec 31, 2023	174	-74	-29.84%
Dec 31, 2022	248	-11	-4.25%
Dec 31, 2021	259	61	30.81%
Dec 31, 2020	198	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

ADAG News

11 days ago - Adagene Expands SAFEbody® Collaboration and License Agreement with Exelixis to Develop Third Novel Masked Antibody-Drug Conjugate - GlobeNewsWire
22 days ago - Adagene's ADG126 to be Highlighted in Two Presentations at the 2025 Chinese Society of Clinical Oncology (CSCO) Meeting in Jinan, China - GlobeNewsWire
24 days ago - Adagene Appoints Immuno-Oncology Pioneer, Axel Hoos, M.D., Ph.D., as Executive Advisor - GlobeNewsWire
4 weeks ago - Adagene to Participate in Two Investor Conferences in September - GlobeNewsWire
6 weeks ago - Adagene Reports Six Months 2025 Financial Results and Provides Corporate Updates - GlobeNewsWire
2 months ago - Adagene Announces Regulatory Update on Clinical Development Plan for Muzastotug in Microsatellite Stable Colorectal Cancer Following Productive Type B (End of Phase 1) Meeting with FDA - GlobeNewsWire
2 months ago - Adagene and ConjugateBio Partner to Develop Novel Antibody Drug Conjugate - GlobeNewsWire
3 months ago - Adagene announces up to $25 million strategic investment from Sanofi - GlobeNewsWire